4//SEC Filing
Stenhouse Mark 4
Accession 0001209191-21-064936
CIK 0001718852other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 9:10 PM ET
Size
5.5 KB
Accession
0001209191-21-064936
Insider Transaction Report
Form 4
Stenhouse Mark
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-14+70,371→ 70,371 totalExercise: $36.32Exp: 2031-11-13→ Common Stock (70,371 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on November 14, 2022, and 1/48th of the shares subject to the option will vest monthly thereafter, subject to the Reporting Person's continued service with the Issuer through each vest date.
Documents
Issuer
Prometheus Biosciences, Inc.
CIK 0001718852
Entity typeother
Related Parties
1- filerCIK 0001734751
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 9:10 PM ET
- Size
- 5.5 KB